Page 103 - 2019_09-HaematologicaMondo-web

Thiazolidinones reduce iron overload
biological activities of thiazolidinone deriva- tives: a review. Bioorg Med Chem. 2012;20(11):3378-3395.
20. Chen ZZ, Wang ZL, Deng CY, et al. (Z)-5-(4- methoxybenzylidene)thiazolidine-2,4-dione protects rats from carbon tetrachloride- induced liver injury and fibrogenesis. World J Gastroenterol. 2012;18(7):654-661.
21. Zhou H, Wu S, Zhai S, et al. Design, synthe- sis, cytoselective toxicity, structure-activity relationships, and pharmacophore of thiazo- lidinone derivatives targeting drug-resistant lung cancer cells. J Med Chem. 2008;51(5): 1242-1251.
22. Hou YL, Zhang SP, Wang L, et al. Estrogen regulates iron homeostasis through govern- ing hepatic hepcidin expression via an estro- gen response element. Gene. 2012;511(2): 398-403.
23. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004;113(9):1271-1276.
24. Cherayil BJ. Pathophysiology of iron home- ostasis during inflammatory states. J Pediatr. 2015;167(4 Suppl):S15-19.
25. Schmidt PJ, Fleming MD. Modulation of hepcidin as therapy for primary and second- ary iron overload disorders preclinical mod- els and approaches. Hematol Oncol Clin North Am. 2014;28(2):387-401.
26. Fung E, Nemeth E. Manipulation of the hep- cidin pathway for therapeutic purposes. Haematologica. 2013;98(11):1667-1676.
27. Wahedi M, Wortham AM, Kleven MD, et al. Matriptase-2 suppresses hepcidin expres- sion by cleaving multiple components of the hepcidin induction pathway. J Biol Chem. 2017;292(44):18354-18371.
28. Chen H, Choesang T, Li H, et al. Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation. Haematologica. 2016;101(3):297- 308.
29. Ganz T. Erythropoietic regulators of iron metabolism. Free Radic Biol Med. 2018;pii: S0891-5849(18)31188-31192.
30. Kautz L, Jung G, Valore EV, Rivella S, Nemeth E, Ganz T. Identification of erythro- ferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014;46(7):678-684.
31. Tanno T, Noel P, Miller JL. Growth differen- tiation factor 15 in erythroid health and dis-
ease. Curr Opin Hematol. 2010;17(3):184-
190.
32. Tanno T, Porayette P, Sripichai O, et al.
Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009;114 (1):181-186.
33. Zhang M, Liu J, Guo WL, Liu X, Liu SJ, Yin HJ. Icariin regulates systemic iron metabo- lism by increasing hepatic hepcidin expres- sion through Stat3 and Smad1/5/8 signaling. Int J Mol Med. 2016;37(5):1379-1388.
34. Lesbordes-Brion JC, Viatte L, Bennoun M, et al. Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood. 2006;108(4):1402-1405.
35. Preza GC, Ruchala P, Pinon R, et al. Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest. 2011;121 (12):4880-4888.
36. Ahmad KA, Ahmann JR, Migas MC, et al. Decreased liver hepcidin expression in the Hfe knockout mouse. Blood Cells Mol Dis. 2002;29(3):361-366.
37. Nicolas G, Viatte L, Lou DQ, et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat Genet. 2003;34 (1):97-101.
38. Liu J, Zhang J, Ginzburg Y, et al. Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered ery- thropoiesis. Blood. 2013;121(8):e43-49.
39. Pryor WA. On the detection of lipid hydroperoxides in biological samples. Free Radic Biol Med. 1989;7(2):177-178.
40. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxida- tion products: malonaldehyde and 4- hydroxynonenal. Methods Enzymol. 1990;186:407-421.
41. Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in beta-tha- lassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood. 2007;109(11):5027-5035.
42. Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Loreal O. Haemochromatosis. Nat Rev Dis Primers. 2018;4:18016.
43. Adamsky K, Weizer O, Amariglio N, et al.
Decreased hepcidin mRNA expression in thalassemic mice. Br J Haematol. 2004;124 (1):123-124.
44. Li H, Rybicki AC, Suzuka SM, et al. Transferrin therapy ameliorates disease in beta-thalassemic mice. Nat Med. 2010;16 (2):177-182.
45. Camaschella C. Iron and hepcidin: a story of recycling and balance. Hematology Am Soc Hematol Educ Program. 2013;2013:1-8.
46. Guo S, Casu C, Gardenghi S, et al. Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice. J Clin Invest. 2013;123(4):1531-1541.
47. Schmidt PJ, Toudjarska I, Sendamarai AK, et al. An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia. Blood. 2013;121(7):1200-1208.
48. Zhen AW, Nguyen NH, Gibert Y, et al. The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology. 2013;58(4):1315-1325.
49. Corradini E, Meynard D, Wu Q, et al. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology. 2011;54(1):273-284.
50. Kautz L, Meynard D, Monnier A, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood. 2008;112(4):1503-1509.
51. Zhang AS, Yang F, Wang JH, Tsukamoto H, Enns CA. Hemojuvelin-neogenin interaction is required for bone morphogenic protein-4- induced hepcidin expression. J Biol Chem. 2009;284(34): 22580-22589.
52. Gao JW, Chen JX, Kramer M, Tsukamoto H, Zhang AS, Enns CA. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metabolism. 2009;9(3):217-227.
53. Du X, She E, Gelbart T, et al. The serine pro- tease TMPRSS6 is required to sense iron defi- ciency. Science. 2008;320(5879):1088-1092.
54. Kent P, Wilkinson N, Constante M, et al. Hfe and Hjv exhibit overlapping functions for iron signaling to hepcidin. J Mol Med (Berl). 2015;93(5):489-498.
55. Kim A, Nemeth E. New insights into iron regulation and erythropoiesis. Curr Opin Hematol. 2015;22(3):199-205.
haematologica | 2019; 104(9)
1781